BR9910898A - Indolinonas sibstituìdas, preparação e utilização das mesmas como composições farmacêuticas - Google Patents
Indolinonas sibstituìdas, preparação e utilização das mesmas como composições farmacêuticasInfo
- Publication number
- BR9910898A BR9910898A BR9910898-4A BR9910898A BR9910898A BR 9910898 A BR9910898 A BR 9910898A BR 9910898 A BR9910898 A BR 9910898A BR 9910898 A BR9910898 A BR 9910898A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- pharmaceutical compositions
- indolinones
- substituted
- specifically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19824922A DE19824922A1 (de) | 1998-06-04 | 1998-06-04 | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
PCT/EP1999/003692 WO1999062882A1 (de) | 1998-06-04 | 1999-05-28 | Substituierte indolinone, ihre herstellung und ihre verwendung als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9910898A true BR9910898A (pt) | 2001-02-13 |
Family
ID=7869856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9910898-4A BR9910898A (pt) | 1998-06-04 | 1999-05-28 | Indolinonas sibstituìdas, preparação e utilização das mesmas como composições farmacêuticas |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1100779A1 (sh) |
JP (1) | JP2002516906A (sh) |
KR (1) | KR20010043973A (sh) |
CN (1) | CN1303374A (sh) |
AU (1) | AU764782B2 (sh) |
BG (1) | BG104938A (sh) |
BR (1) | BR9910898A (sh) |
CA (1) | CA2328291A1 (sh) |
CO (1) | CO5050294A1 (sh) |
DE (1) | DE19824922A1 (sh) |
EA (1) | EA003514B1 (sh) |
EE (1) | EE200000723A (sh) |
HR (1) | HRP20000831A2 (sh) |
HU (1) | HUP0102210A3 (sh) |
ID (1) | ID27035A (sh) |
IL (1) | IL138702A0 (sh) |
NO (1) | NO20006138L (sh) |
PL (1) | PL344467A1 (sh) |
SK (1) | SK18222000A3 (sh) |
TR (1) | TR200003515T2 (sh) |
WO (1) | WO1999062882A1 (sh) |
YU (1) | YU73900A (sh) |
ZA (1) | ZA200005435B (sh) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19816624A1 (de) * | 1998-04-15 | 1999-10-21 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
US6624171B1 (en) | 1999-03-04 | 2003-09-23 | Smithkline Beecham Corporation | Substituted aza-oxindole derivatives |
GB9904933D0 (en) | 1999-03-04 | 1999-04-28 | Glaxo Group Ltd | Compounds |
US6762180B1 (en) | 1999-10-13 | 2004-07-13 | Boehringer Ingelheim Pharma Kg | Substituted indolines which inhibit receptor tyrosine kinases |
UA75054C2 (uk) * | 1999-10-13 | 2006-03-15 | Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг | Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу |
AU2001288374A1 (en) * | 2000-09-01 | 2002-03-22 | Glaxo Group Limited | Substituted oxindole derivatives as tyrosine kinase inhibitors |
WO2002020513A1 (en) * | 2000-09-01 | 2002-03-14 | Glaxo Group Limited | Oxindole derivatives |
DE10117204A1 (de) * | 2001-04-06 | 2002-10-10 | Boehringer Ingelheim Pharma | In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
EP1401415B1 (en) | 2001-06-29 | 2006-06-21 | AB Science | Use of n-phenyl-2-pyrimidine-amine derivatives for treating inflammatory diseases |
WO2003002109A2 (en) * | 2001-06-29 | 2003-01-09 | Ab Science | Use of tyrosine kinase inhibitors for treating autoimmune diseases |
PT1401416E (pt) * | 2001-06-29 | 2007-02-28 | Ab Science | Utilização de inibidores de c-kit para tratar doenças inflamatórias intestinais (dii) |
DE60216281T2 (de) | 2001-06-29 | 2007-07-05 | Ab Science | Die verwendung von tyrosinkinasehemmer zur behandlung von allergischen erkrankungen |
JP2005500041A (ja) | 2001-06-29 | 2005-01-06 | アブ サイエンス | 強力で選択的かつ非毒性のc−kit阻害剤 |
US20030225152A1 (en) * | 2001-09-27 | 2003-12-04 | Andrews Steven W. | 3-(Arylamino)methylene-1, 3-dihydro-2h-indol-2-ones as kinase inhibitors |
US7169936B2 (en) | 2002-07-23 | 2007-01-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments |
JP4879492B2 (ja) * | 2002-11-27 | 2012-02-22 | アラーガン、インコーポレイテッド | 疾患の治療のためのキナーゼ阻害剤 |
DE102004012070A1 (de) * | 2004-03-12 | 2005-09-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue cycloalkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel |
PE20060777A1 (es) * | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
JP5404414B2 (ja) * | 2006-12-05 | 2014-01-29 | アリーナ ファーマシューティカルズ, インコーポレイテッド | (r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンゾアゼピンおよびその中間体を調製するための方法 |
GB0706072D0 (en) | 2007-03-28 | 2007-05-09 | Sterix Ltd | Compound |
US20170065529A1 (en) | 2015-09-09 | 2017-03-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical dosage form for immediate release of an indolinone derivative |
CN101735071A (zh) * | 2009-12-04 | 2010-06-16 | 大连凯飞精细化工有限公司 | 一种生产4-n,n-二甲胺基甲基苯胺的方法 |
CN103102352B (zh) * | 2011-11-15 | 2015-08-12 | 山东亨利医药科技有限责任公司 | 酪氨酸激酶抑制剂吲哚满酮衍生物 |
CN103130775B (zh) * | 2011-11-22 | 2015-09-30 | 山东亨利医药科技有限责任公司 | 作为酪氨酸激酶抑制剂的吲哚满酮衍生物 |
GB201208775D0 (en) * | 2012-05-18 | 2012-07-04 | Uni I Oslo | Chemical compounds |
CN103848814B (zh) * | 2012-12-06 | 2016-08-17 | 山东亨利医药科技有限责任公司 | 作为酪氨酸激酶抑制剂的取代吲哚满酮衍生物 |
WO2024050297A1 (en) * | 2022-09-02 | 2024-03-07 | Deciphera Pharmaceuticals, Llc | Ulk inhibitors and methods of use thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE838623A (fr) * | 1976-02-16 | 1976-06-16 | Derives de 3-hydroxymethylene-2-indolinone et procede pour leur production | |
US4145422A (en) * | 1977-09-06 | 1979-03-20 | Abbott Laboratories | Aminomethylene oxindoles |
US5880141A (en) * | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
EP1247803A3 (en) * | 1996-08-23 | 2002-10-16 | Sugen, Inc. | Indolinone compounds suitable for modulation of protein kinases |
GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
-
1998
- 1998-06-04 DE DE19824922A patent/DE19824922A1/de not_active Withdrawn
-
1999
- 1999-05-28 JP JP2000552094A patent/JP2002516906A/ja active Pending
- 1999-05-28 EP EP99926454A patent/EP1100779A1/de not_active Withdrawn
- 1999-05-28 ID IDW20002523A patent/ID27035A/id unknown
- 1999-05-28 SK SK1822-2000A patent/SK18222000A3/sk unknown
- 1999-05-28 PL PL99344467A patent/PL344467A1/xx unknown
- 1999-05-28 IL IL13870299A patent/IL138702A0/xx unknown
- 1999-05-28 CA CA002328291A patent/CA2328291A1/en not_active Abandoned
- 1999-05-28 KR KR1020007013597A patent/KR20010043973A/ko not_active Application Discontinuation
- 1999-05-28 EA EA200100001A patent/EA003514B1/ru not_active IP Right Cessation
- 1999-05-28 TR TR2000/03515T patent/TR200003515T2/xx unknown
- 1999-05-28 AU AU43707/99A patent/AU764782B2/en not_active Ceased
- 1999-05-28 WO PCT/EP1999/003692 patent/WO1999062882A1/de not_active Application Discontinuation
- 1999-05-28 BR BR9910898-4A patent/BR9910898A/pt not_active IP Right Cessation
- 1999-05-28 EE EEP200000723A patent/EE200000723A/xx unknown
- 1999-05-28 HU HU0102210A patent/HUP0102210A3/hu unknown
- 1999-05-28 CN CN99806884A patent/CN1303374A/zh active Pending
- 1999-05-28 YU YU73900A patent/YU73900A/sh unknown
- 1999-06-04 CO CO99035396A patent/CO5050294A1/es unknown
-
2000
- 2000-10-05 ZA ZA200005435A patent/ZA200005435B/en unknown
- 2000-11-13 BG BG104938A patent/BG104938A/xx active Pending
- 2000-12-01 HR HR20000831A patent/HRP20000831A2/hr not_active Application Discontinuation
- 2000-12-01 NO NO20006138A patent/NO20006138L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EA003514B1 (ru) | 2003-06-26 |
KR20010043973A (ko) | 2001-05-25 |
NO20006138L (no) | 2001-02-01 |
PL344467A1 (en) | 2001-11-05 |
IL138702A0 (en) | 2001-10-31 |
TR200003515T2 (tr) | 2001-06-21 |
HUP0102210A3 (en) | 2002-12-28 |
EE200000723A (et) | 2002-04-15 |
WO1999062882A1 (de) | 1999-12-09 |
DE19824922A1 (de) | 1999-12-09 |
HRP20000831A2 (en) | 2001-12-31 |
AU764782B2 (en) | 2003-08-28 |
JP2002516906A (ja) | 2002-06-11 |
BG104938A (en) | 2001-06-29 |
CA2328291A1 (en) | 1999-12-09 |
CN1303374A (zh) | 2001-07-11 |
AU4370799A (en) | 1999-12-20 |
YU73900A (sh) | 2003-04-30 |
EP1100779A1 (de) | 2001-05-23 |
CO5050294A1 (es) | 2001-06-27 |
EA200100001A1 (ru) | 2001-08-27 |
ZA200005435B (en) | 2002-01-07 |
HUP0102210A2 (hu) | 2001-11-28 |
ID27035A (id) | 2001-02-22 |
NO20006138D0 (no) | 2000-12-01 |
SK18222000A3 (sk) | 2001-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9910898A (pt) | Indolinonas sibstituìdas, preparação e utilização das mesmas como composições farmacêuticas | |
BR9909688A (pt) | Indolinonas substituìdas, a sua preparação e seu uso como composições farmacêuticas | |
BRPI0014735A (pt) | composto 3-z-[1-(4-(n-((4-metil-piperazin-1-il)-metilcarbonil)-n-metil-amino)-anilino)-1-fenil-metileno]-6-metóxicarbonil-2-indolinona, seus sais e seu uso, bem como composição farmacêutica e seu processo de preparação. | |
BR122019010200B8 (pt) | compostos de pirazol-quinazolina, seus sais, produtos ou kits e composições farmacêuticas | |
BR0010716A (pt) | Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas | |
BR9914065A (pt) | Indolinonas substituìdas, sua preparação e seu uso como medicamentos | |
BR9907270A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto | |
BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
BR9911013A (pt) | Derivados de pirazol como inibidores da p-38 map quinase | |
BR0211801A (pt) | Derivados de 7h-pirrolo[2,3-d]pirimidina | |
BR0317283A (pt) | Derivados heterocìclicos de flúor-glicosìdeo, medicamentos contendo estes compostos e seu uso | |
BR9911017A (pt) | Derivados de indol e seu emprego para o tratamento de doenças malignas e outras, que se baseiam na proliferação de células patológicas | |
BRPI0116266B8 (pt) | "derivado de quinazolina e seu uso, bem como composição farmacêutica". | |
BR0312513A (pt) | Derivados de glicosìdeo de tiofeno, processos para a produção dos mesmos, medicamentos que contêm esses compostos e uso dos mesmos | |
BR9910573A (pt) | Compostos antipicornavirais, preparação e uso dos mesmos | |
BRPI0510394A (pt) | inibidores de 11-beta-hidroxiesteróide desidrogenase tipo 1 | |
BR9911488A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto | |
BR0210711A (pt) | Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto | |
BR9915967A (pt) | Derivados de propanolamina substituìdos por arila, proceso para sua preparação, medicamentos contendo estes compostos e seu uso | |
BR0312464A (pt) | Inibidores de tirosina quinases | |
BRPI0411863A (pt) | derivados de pirazolil-indol como inibidores de cinase, processo para seu preparo e composições farmacêuticas compreendendo os mesmos | |
BRPI9917007B8 (pt) | azabicicloalcanos como moduladores de ccr5, composição farmacêutica contendo os mesmos, bem como seu uso | |
BR0214243A (pt) | Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida | |
BR0314379A (pt) | Quinazolinonas espirocondensadas e a sua utilização como inibidores de fosfodiesterase | |
BR0017030B8 (pt) | derivados de tiazolilamida, processo para sua preparação, composição farmacêutica que os compreende e uso dos mesmos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6O, 7O E 8O ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007. |